HIC2 expression is not different between MGMT promoter methylation group and MGMT promoter un‐methylation groups (Figure S3) and as shown in Figure 2E, HIC2 expression did not change after glioma patients were treated with temozolomide. Here, HIC2 is linked to central nervous system cancer.